How funding cuts left Africa vulnerable to Ebola amid crisis

The Democratic Republic of the Congo is facing one of its most severe Ebola outbreaks in years, yet a key scientific alliance that could have curbed the spread remains sidelined. The Centers for Research in Emerging Infectious Diseases (CREID) Network, launched in 2020 by the National Institutes of Health, was designed to track and investigate zoonotic viruses before they leap from animals to humans. With 10 field sites across Central and East Africa—regions repeatedly battered by viral outbreaks—the network was uniquely positioned to respond to the current crisis in Ituri Province.

But last June, the Trump administration issued a stop-work order, abruptly halting CREID’s operations. The justification cited concerns over research safety and taxpayer efficiency, despite the network’s $82 million allocation over five years. The decision came amid a broader shift in federal priorities and, according to reports, was influenced by conspiracy theories linking COVID-19’s origins to international research collaborations.

A network built for rapid response

CREID’s mission was to identify emerging pathogens before they escalated into full-blown epidemics. Researchers at its African sites were studying filoviruses like Ebola, as well as lesser-known threats such as hantavirus—a disease that recently surfaced in an unusual outbreak on a cruise ship. By embedding labs in high-risk regions, the network aimed to shorten the gap between detection and intervention, a strategy proven effective during past outbreaks.

The model mirrored successful initiatives like the PREDICT program, which tracked wildlife reservoirs for zoonotic viruses for over a decade. "These centers were our early warning system," said Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, in a 2024 interview. "Disrupting them without a clear strategic alternative leaves gaps that are hard to fill mid-crisis."

The cost of abrupt defunding

The stop-work order left CREID researchers scrambling. Field teams in Congo, Uganda, and Kenya were forced to pause surveillance, sample collection, and community engagement efforts just as Ebola cases began multiplying. Local health workers, already stretched thin, lost access to critical diagnostic support and real-time data sharing.

Critics argue the decision ignored the network’s tangible impact. Between 2020 and 2024, CREID investigators identified over 40 novel viruses, including several with pandemic potential. In Cameroon alone, their work contributed to the rapid containment of a Marburg virus outbreak in 2022, preventing dozens of deaths.

What comes next?

With the funding cutoff now in its second year, the long-term consequences are becoming clear. Without CREID’s infrastructure, African nations must rely solely on reactive measures—contact tracing, quarantine protocols, and emergency vaccinations—while the world watches case counts rise. Public health experts warn that the delay in restoring support could normalize underpreparedness for future outbreaks.

For now, the Democratic Republic of the Congo’s health ministry is coordinating with partners like the World Health Organization, but the absence of CREID’s boots-on-the-ground expertise leaves critical blind spots. As one epidemiologist noted, "You don’t build resilience by dismantling the systems that protect you."

The question remains: Will policymakers reverse course before the next outbreak strikes—or will Africa’s vulnerability to Ebola and similar threats become a permanent fixture of the 21st century?